The Moradali Laboratory is developing a systems-level framework to understand how emergent immune behaviors arise through the dynamic integration of immune signaling networks and how these behaviors govern the initiation, persistence, and resolution of chronic inflammatory diseases. Rather than viewing immune responses as the consequence of individual receptors or isolated signaling pathways, we investigate immune signaling architecture as the organizational framework through which microbial, environmental, metabolic, and endogenous cues collectively generate biological outcomes that cannot be predicted from the activity of individual signaling components alone.

Using an interdisciplinary approach that integrates systems immunology, molecular immunology, microbiology, biochemistry, quantitative biology, and human translational research, our laboratory investigates how microbiome-derived molecules, microbial metabolites, endogenous danger signals, environmental stressors, and tissue microenvironments reprogram innate immune signaling networks to establish persistent inflammatory states. Our research seeks to uncover systems-level signaling mechanisms, network dynamics, and quantitative principles that explain immune persistence, disease heterogeneity, and chronic inflammatory progression across diverse pathological conditions, including autoimmune diseases, cancer, neuroinflammatory disorders, and oral–systemic inflammatory diseases.

A defining strength of our laboratory is the integration of mechanistic biology with advanced analytical technologies within a unified discovery-to-translation framework. By combining metabolomics, high-resolution mass spectrometry, molecular signaling analyses, structural and functional characterization of immunomodulatory molecules, quantitative immune phenotyping, high-content imaging, multi-omics integration, computational modeling, and clinically relevant human biospecimens, we quantitatively characterize immune signaling architecture across multiple biological scales. This integrated strategy enables the discovery of predictive immune signatures, mechanistic biomarkers, disease-associated signaling architectures, and novel therapeutic targets while establishing robust analytical frameworks for translational immunology.

Our long-term vision extends beyond understanding individual diseases. We seek to establish generalizable biological principles that explain how interacting immune signaling networks generate emergent immune behaviors across chronic inflammatory conditions. By integrating fundamental discovery with human translational investigation and strategic collaboration across academia, clinical medicine, engineering, computational sciences, and industry, we aim to transform systems-level insights into innovative biomarkers, analytical technologies, therapeutic strategies, and precision medicine approaches that redefine the diagnosis, monitoring, and treatment of chronic inflammatory diseases.